CA2235942C - Derives tricycliques d'erythromycine - Google Patents

Derives tricycliques d'erythromycine Download PDF

Info

Publication number
CA2235942C
CA2235942C CA 2235942 CA2235942A CA2235942C CA 2235942 C CA2235942 C CA 2235942C CA 2235942 CA2235942 CA 2235942 CA 2235942 A CA2235942 A CA 2235942A CA 2235942 C CA2235942 C CA 2235942C
Authority
CA
Canada
Prior art keywords
compound
formula
iii
alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2235942
Other languages
English (en)
Other versions
CA2235942A1 (fr
Inventor
Yat Sun Or
Ly Tam Phan
Daniel T. Chu
Kenneth P. Spina
Robert Hallas
Richard L. Elliott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority claimed from PCT/US1996/016585 external-priority patent/WO1997017356A1/fr
Publication of CA2235942A1 publication Critical patent/CA2235942A1/fr
Application granted granted Critical
Publication of CA2235942C publication Critical patent/CA2235942C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La présente invention concerne des composés, ou des sels et des esters de ces composés qui sont acceptables en pharmacie, selon les formules (I); (II); (III) ou (IV) dans lesquelles A, B, D et E, R<1>, R<2> et Z sont spécifiquement définis, présentant une activité antibactérienne, des compositions pharmaceutiques contenant les composés mentionnés, le traitement d'infections bactériennes avec lesdites compositions et des procédés de préparation des composés.
CA 2235942 1995-11-08 1996-10-17 Derives tricycliques d'erythromycine Expired - Fee Related CA2235942C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55524695A 1995-11-08 1995-11-08
US08/555,246 1995-11-08
PCT/US1996/016585 WO1997017356A1 (fr) 1995-11-08 1996-10-17 Derives tricycliques d'erythromycine

Publications (2)

Publication Number Publication Date
CA2235942A1 CA2235942A1 (fr) 1997-05-15
CA2235942C true CA2235942C (fr) 2005-12-06

Family

ID=29405982

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2235942 Expired - Fee Related CA2235942C (fr) 1995-11-08 1996-10-17 Derives tricycliques d'erythromycine

Country Status (1)

Country Link
CA (1) CA2235942C (fr)

Also Published As

Publication number Publication date
CA2235942A1 (fr) 1997-05-15

Similar Documents

Publication Publication Date Title
US6274715B1 (en) Tricyclic erythromycin derivatives
EP0876388B1 (fr) Derives tricycliques d&#39;erythromycine
US6355620B1 (en) C-2 modified erythromycin derivatives
EP1015467B1 (fr) Derives d&#39;erythromycine pontes en 6,9
WO1997042204A1 (fr) Erythromycines 6-o substituees et leur procede de preparation
AU1286799A (en) 6,11-bridged erythromycin derivatives
US4740502A (en) Semisynthetic erythromycin antibiotics
EP1206476B1 (fr) 9a-azalides a activite antibacterienne
NZ233117A (en) 9-deoxo-9,12-epoxy-erythromycin derivatives and pharmaceutical compositions
US20040235760A1 (en) 5-O-mycaminosyltylonide derivatives
EP1181300B1 (fr) Derives ketolide de 6-o-carbamate
US5780604A (en) 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
EP1259923B1 (fr) Agents anti-infectieux utiles contre des souches de bacteries resistant a l&#39;action de plusieurs medicaments
AU714176B2 (en) 3-deoxy-3-descladinose derivatives of erythromycins A and B
US6812216B2 (en) 11-C-substituted derivatives of clarithromycin
US20020193320A1 (en) C-2 modified erythromycin derivatives
EP0307177A2 (fr) Dérivés d&#39;érythromycine
CZ2000811A3 (cs) 6,9-můstkové erythromycinové deriváty a způsob jejich přípravy
MXPA00002335A (es) Derivados de eritromicina unidos en 6,9
MXPA00002216A (en) 3-descladinose 6-o-substituded erythromycin derivatives
CZ20001394A3 (cs) Erythromycinové deriváty s 6,11-přemostěním

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed